Adherence must always be considered: is everolimus really ineffective as a treatment for atopic dermatitis?
- PMID: 19954385
- DOI: 10.3109/09546630903414929
Adherence must always be considered: is everolimus really ineffective as a treatment for atopic dermatitis?
Comment on
-
Severe atopic dermatitis treated with everolimus.J Dermatolog Treat. 2009;20(6):365-7. doi: 10.3109/09546630903085294. J Dermatolog Treat. 2009. PMID: 19954394
Similar articles
-
Severe atopic dermatitis treated with everolimus.J Dermatolog Treat. 2009;20(6):365-7. doi: 10.3109/09546630903085294. J Dermatolog Treat. 2009. PMID: 19954394
-
[Tacrolimus and pimecrolimus ointments in the treatment of atopic eczema].Duodecim. 2003;119(9):825-7. Duodecim. 2003. PMID: 12815980 Finnish. No abstract available.
-
Topical treatment for atopic dermatitis in the 21st century.J Ark Med Soc. 2004 Sep;101(3):86-90. J Ark Med Soc. 2004. PMID: 15384500 Review.
-
[Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].Ned Tijdschr Geneeskd. 2005 May 14;149(20):1096-100. Ned Tijdschr Geneeskd. 2005. PMID: 15932135 Review. Dutch.
-
Successful treatment of severe atopic dermatitis with methotrexate.Clin Exp Dermatol. 2005 Jul;30(4):436-7. doi: 10.1111/j.1365-2230.2005.01766.x. Clin Exp Dermatol. 2005. PMID: 15953091 No abstract available.
Cited by
-
Topical calcineurin and mammalian target of rapamycin inhibitors in inflammatory dermatoses: Current challenges and nanotechnology‑based prospects (Review).Int J Mol Med. 2024 Oct;54(4):85. doi: 10.3892/ijmm.2024.5409. Epub 2024 Aug 12. Int J Mol Med. 2024. PMID: 39129316 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources